Company profile CAPR

Capricor Therapeutics Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: November 05 2023 01:02:32.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
350
inf% YoY inf% QoQ
99
inf% YoY -71.7% QoQ
2021 113
inf% YoY 14.1% QoQ
123
inf% YoY 8.8% QoQ
65
-81.4% YoY -47.2% QoQ
83
-16.2% YoY 27.7% QoQ
2022 89
-21.2% YoY 7.2% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Capricor Therapeutics search interestLast update: October 15 2023 10:43:04.
Correlation coefficient between keyword and revenue is 0.62
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 01:02:32.

The average 5 years interest of Capricor Therapeutics was 3.55 per week.
The last year interest of Capricor Therapeutics compared to the last 5 years has changed by -100.0%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:00:09.

After 39 days of this quarter the interest is at 17.0. Based on that we can calculate that during remaining 52 days it will total up to 40.0.
CAPR stock expected interest is significantly higher compared to same quarter last year (+66.7%) but similar to previous quarter.

YearQ1Q2Q3Q4
20199
10
11.1% QoQ
35
250.0% QoQ
6
-82.9% QoQ
2020 25
177.8% YoY 316.7% QoQ
318
3080.0% YoY 1172.0% QoQ
237
577.1% YoY -25.5% QoQ
69
1050.0% YoY -70.9% QoQ
2021 92
268.0% YoY 33.3% QoQ
53
-83.3% YoY -42.4% QoQ
51
-78.5% YoY -3.8% QoQ
34
-50.7% YoY -33.3% QoQ
2022 60
-34.8% YoY 76.5% QoQ
33
-37.7% YoY -45.0% QoQ
38
-25.5% YoY 15.2% QoQ
31
-8.8% YoY -18.4% QoQ
2023 24
-60.0% YoY -22.6% QoQ
26
-21.2% YoY 8.3% QoQ
40
5.3% YoY 53.8% QoQ
42
35.5% YoY 5.0% QoQ
2024 17
-29.2% YoY -59.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and CAPR stock search interestLast update: February 08 2024 18:00:08.
Correlation coefficient between keyword and revenue is -0.26
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:00:10.

The average 5 years interest of CAPR stock was 4.79 per week.
The last year interest of CAPR stock compared to the last 5 years has changed by -44.26%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 124.37%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for CAP-1002 Duchenne muscular dystrophy to provide analysis

Correlation between past revenue and CAP-1002 Duchenne muscular dystrophy search interest

There is not enough data for CAP-1002 Duchenne muscular dystrophy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for CAP-1002 Duchenne muscular dystrophy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for exosome-based therapeutics to provide analysis

Correlation between past revenue and exosome-based therapeutics search interest

There is not enough data for exosome-based therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for exosome-based therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Capricor Therapeutics clinical trials to provide analysis

Correlation between past revenue and Capricor Therapeutics clinical trials search interest

There is not enough data for Capricor Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Capricor Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 04 2023 11:17:53.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
116
inf% YoY inf% QoQ
271
inf% YoY 133.6% QoQ
2021 339
inf% YoY 25.1% QoQ
233
inf% YoY -31.3% QoQ
104
-10.3% YoY -55.4% QoQ
181
-33.2% YoY 74.0% QoQ
2022 319
-5.9% YoY 76.2% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Vaccines for infectious diseases search interestLast update: November 04 2023 11:17:53.
Correlation coefficient between keyword and revenue is -0.34
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 04 2023 11:17:53.

The average 5 years interest of Vaccines for infectious diseases was 5.99 per week.
The last year interest of Vaccines for infectious diseases compared to the last 5 years has changed by -100.0%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Capricor Therapeutics Lonza collaboration to provide analysis

Correlation between past revenue and Capricor Therapeutics Lonza collaboration search interest

There is not enough data for Capricor Therapeutics Lonza collaboration to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Capricor Therapeutics Lonza collaboration to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:00:15.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Capricor Therapeutics stock news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201935
21
-40.0% QoQ
15
-28.6% QoQ
14
-6.7% QoQ
2020 41
17.1% YoY 192.9% QoQ
57
171.4% YoY 39.0% QoQ
54
260.0% YoY -5.3% QoQ
0
-100.0% YoY -100.0% QoQ
2021 69
68.3% YoY inf% QoQ
42
-26.3% YoY -39.1% QoQ
172
218.5% YoY 309.5% QoQ
28
inf% YoY -83.7% QoQ
2022 0
-100.0% YoY -100.0% QoQ
73
73.8% YoY inf% QoQ
44
-74.4% YoY -39.7% QoQ
27
-3.6% YoY -38.6% QoQ
2023 66
inf% YoY 144.4% QoQ
89
21.9% YoY 34.8% QoQ
89
102.3% YoY 0.0% QoQ
90
233.3% YoY 1.1% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Capricor Therapeutics stock news search interestLast update: February 08 2024 18:00:14.
Correlation coefficient between keyword and revenue is 0.51
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:00:15.

The average 5 years interest of Capricor Therapeutics stock news was 3.93 per week.
The last year interest of Capricor Therapeutics stock news compared to the last 5 years has changed by 43.26%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 132.64%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Capricor Therapeutics San Diego to provide analysis

Correlation between past revenue and Capricor Therapeutics San Diego search interest

There is not enough data for Capricor Therapeutics San Diego to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Capricor Therapeutics San Diego to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 18:00:19.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Capricor Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201927
14
-48.1% QoQ
61
335.7% QoQ
58
-4.9% QoQ
2020 52
92.6% YoY -10.3% QoQ
238
1600.0% YoY 357.7% QoQ
112
83.6% YoY -52.9% QoQ
40
-31.0% YoY -64.3% QoQ
2021 15
-71.2% YoY -62.5% QoQ
27
-88.7% YoY 80.0% QoQ
43
-61.6% YoY 59.3% QoQ
47
17.5% YoY 9.3% QoQ
2022 31
106.7% YoY -34.0% QoQ
13
-51.9% YoY -58.1% QoQ
28
-34.9% YoY 115.4% QoQ
31
-34.0% YoY 10.7% QoQ
2023 40
29.0% YoY 29.0% QoQ
51
292.3% YoY 27.5% QoQ
68
142.9% YoY 33.3% QoQ
25
-19.4% YoY -63.2% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Capricor Therapeutics -stock -company search interestLast update: February 08 2024 18:00:19.
Correlation coefficient between keyword and revenue is -0.13
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:00:20.

The average 5 years interest of Capricor Therapeutics -stock -company was 3.91 per week.
The last year interest of Capricor Therapeutics -stock -company compared to the last 5 years has changed by -14.32%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -1.47%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CAPR
Earnings date: 2024-03-13 After close
Company name: Capricor Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T11:08:54Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $60 Price Target

2026-05-12T20:05:00Z

GlobeNewswire
Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

2026-05-04T20:05:00Z

GlobeNewswire
Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

2026-04-22T13:00:00Z

GlobeNewswire
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

2026-03-13T17:41:13Z

Analyst Upgrades
B. Riley Securities Maintains Buy on Capricor Therapeutics, Raises Price Target to $63

2026-03-13T16:28:56Z

Analyst Upgrades
Piper Sandler Reiterates Overweight on Capricor Therapeutics, Raises Price Target to $58

2026-03-13T11:37:29Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $60 Price Target

2026-03-12T20:01:00Z

GlobeNewswire
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

2026-03-12T13:00:00Z

GlobeNewswire
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

2026-03-10T14:49:55Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Capricor Therapeutics, Maintains $60 Price Target

2026-03-10T13:25:00Z

GlobeNewswire
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

2026-03-09T12:30:00Z

GlobeNewswire
Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

2026-02-24T14:00:00Z

GlobeNewswire
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference

2026-01-20T14:15:00Z

GlobeNewswire
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data

2025-12-16T21:05:00Z

GlobeNewswire
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy